Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.

Lurz P, Hahn RT, Kodali S, Makkar R, Sharma RP, Davidson CJ, O'Neill BP, Yadav P, Zahr F, Chadderdon S, Eleid MF, Szerlip M, Smith RL, Whisenant B, Garcia S, Kister T, Kipperman RM, Lim DS, Saxon J, Kapadia S, Hermiller J, Mishell JM, Rassi A, Herrmann HC, Szeto W, Hausleiter J, Babaliaros V, Barker CM, Lindman BR, Latib A, Muhammad K, von Bardeleben RS, Summers M, Chetcuti SJ, Ailawadi G, Russo M, Rinaldi M, Chehab BM, Nickenig G, Stinis C, Inglessis-Azuaje I, Dhoble A, Chhatriwalla AK, Petrossian G, Shah P, Staniloae C, Williams M, Nores M, McCabe JM, Singh G, Baldus S, Rudolph V, Barb I, Klodell C, Gray W, Strote J, Sannino A, Grayburn P, Mack MJ, Leon MB, Thourani VH

Open source

DOI
10.1093/eurheartj/ehaf676
Published
2026 May 5
Container
European heart journal
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehaf676,
  title = {Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.},
  author = {Lurz P and Hahn RT and Kodali S and Makkar R and Sharma RP and Davidson CJ and O'Neill BP and Yadav P and Zahr F and Chadderdon S and Eleid MF and Szerlip M and Smith RL and Whisenant B and Garcia S and Kister T and Kipperman RM and Lim DS and Saxon J and Kapadia S and Hermiller J and Mishell JM and Rassi A and Herrmann HC and Szeto W and Hausleiter J and Babaliaros V and Barker CM and Lindman BR and Latib A and Muhammad K and von Bardeleben RS and Summers M and Chetcuti SJ and Ailawadi G and Russo M and Rinaldi M and Chehab BM and Nickenig G and Stinis C and Inglessis-Azuaje I and Dhoble A and Chhatriwalla AK and Petrossian G and Shah P and Staniloae C and Williams M and Nores M and McCabe JM and Singh G and Baldus S and Rudolph V and Barb I and Klodell C and Gray W and Strote J and Sannino A and Grayburn P and Mack MJ and Leon MB and Thourani VH},
  year = {2026},
  journal = {European heart journal},
  doi = {10.1093/eurheartj/ehaf676},
  url = {https://doi.org/10.1093/eurheartj/ehaf676}
}

RIS

TY  - JOUR
TI  - Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.
AU  - Lurz P
AU  - Hahn RT
AU  - Kodali S
AU  - Makkar R
AU  - Sharma RP
AU  - Davidson CJ
AU  - O'Neill BP
AU  - Yadav P
AU  - Zahr F
AU  - Chadderdon S
AU  - Eleid MF
AU  - Szerlip M
AU  - Smith RL
AU  - Whisenant B
AU  - Garcia S
AU  - Kister T
AU  - Kipperman RM
AU  - Lim DS
AU  - Saxon J
AU  - Kapadia S
AU  - Hermiller J
AU  - Mishell JM
AU  - Rassi A
AU  - Herrmann HC
AU  - Szeto W
AU  - Hausleiter J
AU  - Babaliaros V
AU  - Barker CM
AU  - Lindman BR
AU  - Latib A
AU  - Muhammad K
AU  - von Bardeleben RS
AU  - Summers M
AU  - Chetcuti SJ
AU  - Ailawadi G
AU  - Russo M
AU  - Rinaldi M
AU  - Chehab BM
AU  - Nickenig G
AU  - Stinis C
AU  - Inglessis-Azuaje I
AU  - Dhoble A
AU  - Chhatriwalla AK
AU  - Petrossian G
AU  - Shah P
AU  - Staniloae C
AU  - Williams M
AU  - Nores M
AU  - McCabe JM
AU  - Singh G
AU  - Baldus S
AU  - Rudolph V
AU  - Barb I
AU  - Klodell C
AU  - Gray W
AU  - Strote J
AU  - Sannino A
AU  - Grayburn P
AU  - Mack MJ
AU  - Leon MB
AU  - Thourani VH
PY  - 2026
JO  - European heart journal
DO  - 10.1093/eurheartj/ehaf676
UR  - https://doi.org/10.1093/eurheartj/ehaf676
ER  - 

APA

P, L., RT, H., S, K., R, M., RP, S., CJ, D., BP, O., P, Y., F, Z., S, C., MF, E., M, S., RL, S., B, W., S, G., T, K., RM, K., DS, L., J, S., S, K., J, H., JM, M., A, R., HC, H., W, S., J, H., V, B., CM, B., BR, L., A, L., K, M., RS, V. B., M, S., SJ, C., G, A., M, R., M, R., BM, C., G, N., C, S., I, I., A, D., AK, C., G, P., P, S., C, S., M, W., M, N., JM, M., G, S., S, B., V, R., I, B., C, K., W, G., J, S., A, S., P, G., MJ, M., MB, L., & VH, T. (2026). Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity: the TRISCEND II trial.. European heart journal. https://doi.org/10.1093/eurheartj/ehaf676

Source records